Skip to content

Clinical Study for Gu-Biao Jie-Du-Ling in Preventing of Novel Coronavirus Pneumonia (COVID-19) in Children

Clinical Study for Gu-Biao Jie-Du-Ling in Preventing of Novel Coronavirus Pneumonia (COVID-19) in Children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029487
Enrollment
Unknown
Registered
2020-02-02
Start date
2020-02-10
Completion date
Unknown
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19) in children

Interventions

Experimental group:Isolation and oral Gubiao Jiedu Ling Chinese medicine

Sponsors

Wuhan Hospital of Integrated Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy children between the ages of 1 and 18 who meet the TCM constitutional doctrine: (1) Main features: moderate body shape, ruddy complexion, energetic, etc .; (2) Common manifestations: Symmetric body shape, complexion, moisturized complexion, thick and shiny hair, bright eyes, clear nose, moist olfactory, rosy lips, not easy to fatigue, energetic, cold and heat tolerance, good sleep, stomach Najia, the second stool is normal, the tongue is reddish, the moss is thin and white, the veins are gentle and strong, and the fingerprint is faint purple. Lively and cheerful character. Usual disease is less common.

Exclusion criteria

Exclusion criteria: 1. Clinical suspected or confirmed cases [Refer to the recommendations for diagnosis and treatment of 2019-nCoV infection in children in Hubei Province (trial version 1)] 2. Those who have received other traditional Chinese medicine, proprietary Chinese medicines or immunomodulators to prevent new coronavirus pneumonia; 3. Participants in clinical trials of other drugs in the past 12 weeks; 4. People with other serious primary diseases such as cardiovascular and cerebrovascular diseases, liver and kidney or hematopoietic diseases, genetic metabolic diseases; 5. Those who are known to be allergic to the test drug and its ingredients; 6. Other constitutions in TCM constitution theory.

Design outcomes

Primary

MeasureTime frame
body temperature;Whole blood count and five classifications;C-reactive protein;

Secondary

MeasureTime frame
cough;Lung CT;

Countries

China

Contacts

Public ContactSu Wen

Wuhan Hospital of Integrated Traditional Chinese and Western Medicine

784404524@qq.com+86 13659897175

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026